Global BioAccess Fund
Venture Capital and Private Equity Principals • 
Manhattan, New York, United States • 1-10 Employees
Company overview
| Headquarters | 880 3rd Avenue, New York, New York 10022, US |
| Website | |
| NAICS | 52391 |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
Key Contact at Global BioAccess Fund
Lisa Wisniewski
Managing Director
Global BioAccess Fund Email Formats
Global BioAccess Fund uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@globalbioaccess.com), used 85.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@globalbioaccess.com | 85.7% |
{first name}{last name} | johndoe@globalbioaccess.com | 14.3% |
About Global BioAccess Fund
At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.
Global BioAccess Fund revenue & valuation
| Annual revenue | $855,550 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Venture Capital and Private Equity Principals industry and current estimated revenues | $2,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Global BioAccess Fund has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
Global BioAccess Fund has never raised funding before.
Global BioAccess Fund Tech Stack
Discover the technologies and tools that power Global BioAccess Fund's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Accessibility
PaaS
Blogs
Miscellaneous
Programming languages
Miscellaneous
Security
JavaScript frameworks
Blogs
Slovenia
Australia
Frequently asked questions
4.8
40,000 users
